Wednesday, March 23, 2020
WellDyne is closely monitoring the COVID-19 outbreak and making appropriate operational adjustments to ensure adequate drug supply and high levels of service for our customers.
High Service Levels
We now have more than 80% of our staff working from home, which helps lower the risk of virus exposure in our physical locations.
- We have maintained our high service levels in the pharmacy and contact center during the transition of many of our team members to work from home status.
- We are closely monitoring key metrics such as average speed of answer, call abandonment, shipping turnaround time and are pleased to report we are promptly serving your members.
- Today’s extraordinary circumstances call for increased compassion and understanding. Plan members needing assistance have reached out to thank the WellDyne team for not only quick answers to their questions, but for the caring attitudes of our representatives. We appreciate this feedback and are sharing it with the team members on our front lines.
Home Delivery Options
Keeping an appropriate supply of medication on hand without venturing into public places is a concern that many members of the public face right now.
- You may have heard that retail pharmacies such as CVS and Walgreens are offering local delivery to patients’ homes, which we support during this national emergency.
- Our WellDyne mail order pharmacy is an excellent solution for plan members, whether their needs are for routine, maintenance prescriptions or specialty drugs.
- With free standard shipping, members can receive the medications they need without leaving their homes. Most members also save money on the cost of their prescriptions when using home delivery.
Medication Access
We are continually monitoring prescription drug usage and drug supply, and at this time do not anticipate potential shortages of medications.
- As a reminder, we have activated our national priority refill process which allows members to refill medications earlier than normally allowed.
- While no products are currently approved for the treatment of COVID-19, we have no prior authorization requirements for medications that may be prescribed in an effort to treat or prevent the virus.
The WellDyne leadership team meets daily to discuss our response to the COVID-19 outbreak and related issues. You can count on us for regular updates in the days ahead regarding the steps we are taking on your behalf. Although we are living in unprecedented times, our team continues to lean in to anticipate and overcome any challenges, to best support you and help “flatten the curve.” Our thoughts go out to everyone affected by this crisis.
Source: Welldyne Rx
